tiprankstipranks
N4 Pharma PLC (GB:N4P)
LSE:N4P

N4 Pharma (N4P) Price & Analysis

Compare
3 Followers

N4P Stock Chart & Stats


---

Financials

Quarterly

N4P FAQ

What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.36p and its highest was 0.92p in the past 12 months.
    What is N4 Pharma PLC’s market cap?
    N4 Pharma PLC’s market cap is £6.24M.
      When is N4 Pharma PLC’s upcoming earnings report date?
      N4 Pharma PLC’s upcoming earnings report date is Sep 17, 2025 which is in 206 days.
        How were N4 Pharma PLC’s earnings last quarter?
        N4 Pharma PLC released its earnings results on Sep 24, 2024. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
          Is N4 Pharma PLC overvalued?
          According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does N4 Pharma PLC pay dividends?
            N4 Pharma PLC does not currently pay dividends.
            What is N4 Pharma PLC’s EPS estimate?
            N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does N4 Pharma PLC have?
            N4 Pharma PLC has 394,780,330 shares outstanding.
              What happened to N4 Pharma PLC’s price movement after its last earnings report?
              N4 Pharma PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of N4 Pharma PLC?
                Currently, no hedge funds are holding shares in GB:N4P
                ---

                Company Description

                N4 Pharma PLC

                N4 Pharma PLC is a United Kingdom-based specialist pharmaceutical company. The company is engaged in reformulating existing drugs and vaccines to improve their performance to benefit the patients. The group operates in one business segment, that of the development and commercialization of medicines via its delivery system called Nuvec.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Directa Plus
                Physiomics
                Sareum Holdings
                Scancell Holdings
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis